ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 531 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $19,316 | +14.3% | 247,672 | -0.7% | 0.08% | +11.4% |
Q1 2024 | $16,899 | +3.2% | 249,426 | +2.6% | 0.07% | -7.9% |
Q4 2023 | $16,376 | +26.1% | 243,144 | +26.8% | 0.08% | +5.6% |
Q3 2023 | $12,988 | +3.6% | 191,793 | +9.5% | 0.07% | +4.3% |
Q2 2023 | $12,531 | +34.7% | 175,086 | +27.6% | 0.07% | +13.1% |
Q4 2022 | $9,300 | -99.9% | 137,166 | +3.6% | 0.06% | +10.9% |
Q3 2022 | $7,260,000 | +1.4% | 132,383 | +22.1% | 0.06% | +1.9% |
Q2 2022 | $7,163,000 | +14.6% | 108,423 | +15.0% | 0.05% | +22.7% |
Q1 2022 | $6,253,000 | +24.8% | 94,262 | +9.6% | 0.04% | +22.2% |
Q4 2021 | $5,011,000 | -0.6% | 86,023 | +2.5% | 0.04% | -10.0% |
Q3 2021 | $5,043,000 | +24.1% | 83,964 | +23.8% | 0.04% | +17.6% |
Q2 2021 | $4,063,000 | +44.7% | 67,830 | +20.1% | 0.03% | +25.9% |
Q1 2021 | $2,808,000 | +9.5% | 56,481 | +10.1% | 0.03% | 0.0% |
Q4 2020 | $2,565,000 | +3.2% | 51,307 | +13.2% | 0.03% | -12.9% |
Q3 2020 | $2,485,000 | +5.1% | 45,341 | +1.5% | 0.03% | -3.1% |
Q2 2020 | $2,364,000 | +39.7% | 44,692 | +18.0% | 0.03% | +10.3% |
Q1 2020 | $1,692,000 | +25.5% | 37,887 | +40.1% | 0.03% | +52.6% |
Q4 2019 | $1,348,000 | +13.7% | 27,045 | +1.7% | 0.02% | 0.0% |
Q3 2019 | $1,186,000 | +12.6% | 26,601 | +4.3% | 0.02% | +26.7% |
Q2 2019 | $1,053,000 | +6.5% | 25,505 | +4.3% | 0.02% | 0.0% |
Q1 2019 | $989,000 | -49.6% | 24,457 | -52.7% | 0.02% | -57.1% |
Q4 2018 | $1,963,000 | -14.8% | 51,683 | -11.3% | 0.04% | -10.3% |
Q3 2018 | $2,304,000 | +2.1% | 58,239 | -9.4% | 0.04% | -20.4% |
Q2 2018 | $2,256,000 | -6.4% | 64,268 | -6.7% | 0.05% | -3.9% |
Q1 2018 | $2,410,000 | -13.5% | 68,904 | -14.2% | 0.05% | -3.8% |
Q4 2017 | $2,786,000 | +17.0% | 80,293 | +14.2% | 0.05% | +8.2% |
Q3 2017 | $2,382,000 | +30.8% | 70,294 | +31.6% | 0.05% | +40.0% |
Q2 2017 | $1,821,000 | +19.3% | 53,422 | +9.0% | 0.04% | +12.9% |
Q1 2017 | $1,527,000 | – | 49,031 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |